Importance of metal ion metabolism and oxidative stress in male patients suffered with porphyria cutanea tarda;A fémion-metabolizmus és az oxidatív stressz jelentosége porphyria cutanea tarda betegségben szenvedo férfiakban

Orvosi Hetilap

Volumn 148, Issue 23, 2007, Pages 1095-1100

  Székely, Edit ^a,d   Tasnádi, Gyöngyi ^a   Szentmihályi, Klára ^b   Almási, Andrea ^a   Bor, Márta ^a   Fehér, János ^c   Blázovics, Anna ^c  

^a Budai MAV Korhaz   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d NONE   (Hungary)

Author keywords

Free radical reaction; Iron; Porphyrin; Trace element; Uroporphyrinogen decarboxylase

Indexed keywords

ANTIOXIDANT; ESTROGEN; HEME; METAL ION; PORPHYRIN; UROPORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE; IRON; TRACE ELEMENT;

ALCOHOL CONSUMPTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; ENZYME ACTIVITY; HUMAN; LIPID PEROXIDATION; METAL METABOLISM; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PHLEBOTOMY; PHOTOSENSITIVITY; PORPHYRIA CUTANEA TARDA; SUN EXPOSURE; THERAPY EFFECT; VIRUS INFECTION; ADULT; AGED; ALCOHOL LIVER DISEASE; GENETICS; IRON OVERLOAD; LIVER; MALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION;

ADULT; AGED; HUMANS; IRON; IRON OVERLOAD; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PORPHYRINS; TRACE ELEMENTS; UROPORPHYRINOGEN DECARBOXYLASE;

EID: 34547682234     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28103     Document Type: Article

References (47)

1. Norman, R. A.: Past and Future: Porphyria and Porphyrins. Skinmed., 2005, 5, 287-292.
2. Moore, M. R., McColl, K. E. L., Rimington, C. és mtsa: Disorders of porphyrin metabolism. Plenum Med. Book. Comp. New York-London, 1987, 3-5.
3. Horkay I.: A cutan porphyriák korszeru diagnosztikája és terápiája. Borgyógy. és Venerol. Szemle, 2003, 76, 193-196.
4. Koszó F., Morvay M., Dobozy A. és mtsa: Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda. Br. J. Dermatol., 1992, 126, 446-449.
5. Székely E.: Redox-homeostasis vizsgálata és az antioxidáns kiegészíto kezelés hatása porphyria cutanea tardában. PhD-értekezés, 2006.
6. Elder, G. H.: Metabolic abnormalities in the porphyrias. In: Mascaro J. M. Editor. Seminars in dermatology. Orlando F. L.: Grune & Stratton. 1986, 88-98.
7. Sampietro, M., Piperno, A., Lupica, L. és mtsai: High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology, 1998, 27, 181-184.
8. Roberts, G. A., Whatley, S. D., Morgan, R. R. és mtsai: Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet, 1997, 349, 321-323.
9. Lamoril, J., Andant, C., Gouya, L. és mtsai: Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT). Cell. Mol. Biol., 2002, 48, 33-41.
10. Nordmann, R., Puy, H.: Human hereditary hepatic porphyrias. Clin. Chim. Acta, 2002, 32, 17-37.
11. Fodinger, M., Sunder-Plassmann, G.: Inherited disorders of iron metabolism. Kidney Int., 1999, 55, Suppl 69, S22-S34.
12. Huerter, C. J., Kunkel J. R., Stinson R.: Porphyria cutanea tarda in association with human immnunodeficiency virus (HLV) infection. Nebraska Med. J., 1993, 78, 155-157.
13. Loustaud-Ratti, V., Lunel, F.: Extrahepatic manifestations of hepatitis C virus infection. Rev. Prat., 2000, 50, 1089-1093.
14. Guennoun, N., Gerolami-Colombani, V., Sebti, A. és mtsa: Sporadic porphyria cutanea tarda: a case report in a Moroccan man. Med. Trop., 2003, 63, 183-187.
15. Moore, M. R., McColl, K. E. L., Rimington, C. és mtsai: Disorders of porphyrin metabolism. Plenum Med. Book Comp., New York-London, 1987.
16. Ippen, H.: Kausalfaktoren der porphyria cutanea tarda. Derm. Wochenschr., 1967, 153, 1351-1355.
17. Franklin, M. R., Phillips J. D., Kushner, J. P.: Uroporphyria in the uroporfirinogen decarboxylase-deficient mouse: Interplay with siderosis and polychlorinated biphenyl exposure. Hepatol., 2002, 36, 805-811.
18. Bulaj, Z. J., Franklin, M. R., Phillips, J. D. és mtsai: Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda. J. Lab. Clin. Med., 2000, 136, 482-488.
19. Bonkovsky, H. L., Obando, J. V.: Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis. Curr. Gastroenterol. Rep., 1999, 1, 30-37.
20. Thunell, S., Harper, P.: Porfirins, porfirin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda - suggestions for a handling programme. Scand. J. Clin. Lab. Invest., 2000, 60, 561-580.
21. Kauppinen, R.: Porphyrias. Lancet, 2005, 365, 241-252.
22. Bulaj, Z. J., Phillips, J. D., Ajioka, R. S. és mtsai: Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood, 2000, 95, 1565-1571.
23. Hermann, G., Wlaschek, M., Botsen, K. és mtsai: Photosensitisation of uroporfirin augments the ultraviolet A-induced synthesis of matrix mtalloproteinases in human dermal fibroblasts. J. Invest. Dermatol., 1996, 107, 398-403.
24. Mukerji S. K., Pimstone N. R.: Free radical mechanism of oxidation of uroporphyrinogen in the presence of ferrous iron. Arch. Biochem. Biophysics, 1990, 281, 177-184.
25. Smith A. G., De Matteis F.: Oxidative injury mediated by the hepatic cytochrome P-450 system in cojunction with cellular iron. Effects on the pathway of haem biosynthesis. Xenobiotica, 1990, 20, 865-877.
26. Horváth M. E., Faux S. P., Smith A. G., és mtsai: Vitamin E protects against iron-hexachlorobenzene induced porphyria and formation of 8-hydroxy-deoxy guanoside in the liver of C57BL/10SeSa mice. Toxicology Lett., 2001, 122, 97-102.
27. Mazzetti, M. B., Taira, M. C., Lelli, S. M. és mtsai: Hexachlorobenzene impairs glucose metabolism in a rat model of porphyria cutanea tarda: a mechanistic approach. Arch. Toxicol., 2004, 78, 25-33.
28. Dursun, E., Dursun, B., Suleymanlar, G. és mtsa: Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus. Acta Diabetol., 2005, 42, 123-128.
29. Arosio, R., Levi S.: Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol., Med., 2002, 33, 457-446.
30. Waluga, M., Hartleb, M.: Alcoholic liver disease. Wiad. Lek., 2003, 56, 61-70.
31. Pastor, I. J., Laso, F. J, Romero A. és mtsa: -238 G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men. Alc. Clin. Exp. Res., 2005, 29, 1928-1931.
32. Doss, M. O., Kuhnel, A., Gross, U. és mtsa: Hepatic porphyrias and alcohol. Medizinische Klinik., 1999, 94, 314-328.
33. Homann, N., Stickel, F., Konig, I. R. és mtsai: Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int. J. Cancer., 2006, 118, 1998-2002.
34. Hagymási K., Blázovics A., Lengyel G. és mtsai: Oxidative damage in alcoholic liver disease. Eur. J. Gastroent. Hepatol., 2000, 2, 1-8.
35. Sergent, O., Tomasi, A., Ceccarelli, D. és mtsai: Combination of Iron Overload Plus Ethanol and Ischemia Alone Give Rise to the Same Endogenous Free Iron Pool. Biometals, 2005, 18, 567-575.
36. Jacobs, J. M., Sinclair, P. R., Lambrecht, R. W. és mtsai: Effects of iron-EDTA on uroporphyrinogen oxidation by liver microsomes. FEBS Lett., 1989, 250, 349-352.
37. Sinclair, P., Lambrecht, R., Sinclair, J.: Evidence for cytochrome P450-mediated oxidation of uroporphyrinogen by cell-free liver extracts from chick embryos treated with 3-methylcholanthrene. Biochem. Biophys. Res. Commun., 1987, 146, 1324-1329.
38. Sigel, A., Sigel, H.: Iron transport and storagen microorganisms, plants and animals. Metal Ions Biol. Syst., 1998, 35, 1-775.
39. Lakatos B., Szentmihályi K., Vinkler P. és mtsai: A vas fiziológiás és patológiás szerepe az emberi szervezet muködésében. Az újszülöttek vashiányos anémiája. Orv. Hetil., 2004, 145, 1853-1859.
40. Szentmihályi K., Kocsis I., Rapavi E. és mtsai: Magnesium therapy in hyperlipidemy. Z. Gastronenterol., 2005, 43, 515.
41. Isik, B., Isik, R. S., Ceylan, A. és mtsai: Trace elements and oxidative stress in chronic obstructive pulmonary disease. Saudi Med. J., 2005, 26, 1882-1885.
42. Blázovics A., Szentmihályi K., Vinkler P. és mtsa: Zn overdose may cause disturbance in the iron metabolism. Trace Elem. Electrol., 2004, 21, 240-247.
43. Mackenzie, G. G., Zago M. P., Erlejman A. G. és mtsai: Alfa-Lipoic acid and N-acetyl cysteine prevent zinc deficiency-induced activation of NF-kappaB and AP-1 transcription factors in human neuroblastoma IMR-32 cells. Free Radic Res., 2006, 40, 75-84.
44. Baskurt, O., Temiz, A., Meiselman, H.: Effect of superoxide anions on red blood cell rheologic properties. Free Rad. Biol. Med., 1998, 24, 102-110.
45. Dinya M., Székely E., Szentmihályi K. és mtsai: Element analysis in the total blood of the phlebotomized patients with porphyria cutanea tarda. Trace Elem. Med. Biol., 2005, 19, 217-220.
46. Székely E., Szentmihályi K., Tasnádi Gy. és mtsai: Redoxhomeostasis and element status of the porphyria cutanea tarda patients with diabetes mellitus and alcoholism. Z. Gastroenterol., 2004, 42, 403-452.
47. Székely B., Szentmihályi K., Tasnádi G. és mtsai: Element status of total blood and redox homeostasis of phlebotomized sporadic porphyria cutanea tarda patients with diabetes mellitus and in heavy drinkers. Trace Elem. Electrolyt., 2006, 1, 43-49.